Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yan-Ni Lv"'
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 986-1000 (2024)
Abstract Aim Myocardial injury is a significant cause of death. This study investigated the role and underlying mechanism of interferon‐regulatory factor‐1 (IRF1) in bevacizumab (BVZ)‐induced cardiomyocyte injury. Methods and results HL‐1 cel
Externí odkaz:
https://doaj.org/article/a41d597d9cf5484db4be80a979c023ec
Publikováno v:
Toxicol Res (Camb)
Bevacizumab (BVZ) is the first recombinant humanized monoclonal antibody against vascular endothelial growth factor (VEGFA) approved by the FDA for the treatment of different kinds of cancers, especially colorectal cancer. Although the anti-tumor eff
Publikováno v:
Chinese journal of natural medicines. 14(7)
The present study was designed to investigate whether a combination of four effective components derived from Sheng-mai san (SMXZF; ginsenoside Rb1: ginsenoside Rg1: DT-13: Schizandrol A as 6 : 9 : 4 : 5) could attenuate hydrogen peroxide (H2O2)-indu
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 40(3)
Danhong injection is a compound preparation of traditional Chinese medicine Salvia miltiorrhiza and Carthamus tinctorius, and has been widely applied in treating coronary heart diseases and ischemic encephalopathy in clinic. Despite the complexity of
Publikováno v:
Chinese journal of natural medicines. 12(4)
Aim To illuminate the molecular targets for schisandrin against cerebrovascular disease based on the combined methods of network pharmacology prediction and experimental verification. Method A protein database was established through constructing the
Autor:
Ai-Jun Ouyang1 aijunouyang327@126.com, Yan-Ni Lv1, Hai-Li Zhong1, Jin-Hua Wen1, Xiao-Hua Wei1, Hong-Wei Peng1, Jian Zhou1, Li-Li Liu1
Publikováno v:
American Journal of Cardiology. Apr2015, Vol. 115 Issue 7, p901-906. 6p.